Control / Standard of Care Comparator / Heart Failure / Domain Intervention(s) · Interventional Study
ClinicalTrials.gov · September 9, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a registry record for a planned multicenter randomized platform trial in heart failure that has not yet begun recruitment and has posted no results. The record documents the trial structure and primary outcome measure only; no efficacy data are available.
Interventional, Non Randomized, Sequential, Open label, Treatment purpose. Heart Failure; age from 18 Years; accepts healthy volunteers. Intervention: Active Domain Intervention(s). Compared with: Control / Standard of Care Comparator — Placebo Comparator. n = 1,000.
This is a registry record for a planned multicenter randomized platform trial in heart failure that has not yet begun recruitment and has posted no results. The record documents the trial structure and primary outcome measure only; no efficacy data are available.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is a planned interventional platform trial with no results reported; it describes study design and enrollment targets only, making it a registration record rather than evidence of efficacy.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07428135). This is a study registration, not published results. Lead sponsor: University of Alberta. Recruitment status: NOT_YET_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 1000 participants (ESTIMATED). Conditions: Heart Failure. Interventions: OTHER: Domain Intervention(s); OTHER: Control / Standard of Care Comparator. Primary outcome measures: Time to first occurrence of all-cause death or cardiovascular hospitalization , Up to 365 days (or as defined in domain-specific protocol). Brief summary: The Heart Failure Efficacy and Research Trial (HEART) Platform is a multicenter, randomized platform study designed to improve outcomes for patients with heart failure through the simultaneous and sequential evaluation of multiple interventions across the spectrum of heart failure.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.